 ATLANTA, GA, June 04, 2020 GLOBE NEWSWIRE -- via NEWMEDIAWIRE --GeoVax Labs, Inc. GOVX, a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, is pleased to announce that it has been approved to trade on the OTCQB Venture Market as of June 4, 2020. I would like to thank our shareholders for their support as GeoVax worked toward this important milestone, stated David Dodd, President CEO of GeoVax. 